CyCa OncoSolutions

CyCa OncoSolutions Overview

  • Founded
  • 2017
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 3

CyCa OncoSolutions General Information


Developer of molecular devices designed for programmable delivery of anticancer drugs directly into the cells. The company's molecular devices cross the membrane bilayer and deliver functional molecules into the cytoplasm or other cellular organelles, enabling pharmaceutical and biotechnology companies to create new kind of anti-cancer drugs which may consist of increased brand lifecycle within them.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Primary Office
  • The Rubicon Centre
  • CIT Campus, Bishopstown
  • Cork
  • Ireland
+353 089 000 0000

CyCa OncoSolutions Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CyCa OncoSolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 31-Jul-2019 00000 Completed Startup
3. Early Stage VC 25-Jul-2018 00000 Completed Startup
2. Grant 09-Dec-2017 $771.90 $100K Completed Startup
1. Accelerator/Incubator 10-May-2017 $100K $100K Completed Startup

CyCa OncoSolutions Executive Team (3)

Name Title Board Seat Contact Info
Nusrat Sanghamitra Ph.D Co-Founder & Chief Executive Officer
Valmiki Kempadoo Co-Founder

1 Former Executive

CyCa OncoSolutions Investors (3)

To view CyCa OncoSolutions‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
SOSV Accelerator/Incubator Minority 000 0000 000000 0
India Innovation Initiative Accelerator/Incubator 000 0000 000000 0
RebelBio Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial